Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase

  • James Kempson
  • , Junqing Guo
  • , Jagabandhu Das
  • , Robert V. Moquin
  • , Steven H. Spergel
  • , Scott H. Watterson
  • , Charles M. Langevine
  • , Alaric J. Dyckman
  • , Mark Pattoli
  • , James R. Burke
  • , Xiao Xia Yang
  • , Kathleen M. Gillooly
  • , Kim W. McIntyre
  • , Laishun Chen
  • , John H. Dodd
  • , Murray McKinnon
  • , Joel C. Barrish
  • , William J. Pitts

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

A new series of tricyclic-based inhibitors of IKK have been derived from an earlier lead compound. The synthesis and structure-activity relationships (SAR) are described. Compound 4k inhibited TNF production in rats stimulated with LPS.

Original languageEnglish (US)
Pages (from-to)2646-2649
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number10
DOIs
StatePublished - May 15 2009

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase'. Together they form a unique fingerprint.

Cite this